1. Home
  2. GORO vs NERV Comparison

GORO vs NERV Comparison

Compare GORO & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gold Resource Corporation

GORO

Gold Resource Corporation

HOLD

Current Price

$1.49

Market Cap

212.0M

ML Signal

HOLD

Logo Minerva Neurosciences Inc

NERV

Minerva Neurosciences Inc

HOLD

Current Price

$5.52

Market Cap

228.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GORO
NERV
Founded
1998
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
212.0M
228.5M
IPO Year
2010
2014

Fundamental Metrics

Financial Performance
Metric
GORO
NERV
Price
$1.49
$5.52
Analyst Decision
Strong Buy
Hold
Analyst Count
2
1
Target Price
$1.63
$7.00
AVG Volume (30 Days)
1.7M
322.6K
Earning Date
05-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
91.80
N/A
EPS
N/A
N/A
Revenue
$99,759,000.00
$41,175,600.00
Revenue This Year
$25.99
N/A
Revenue Next Year
$5.78
N/A
P/E Ratio
N/A
N/A
Revenue Growth
51.78
N/A
52 Week Low
$0.35
$1.30
52 Week High
$1.87
$12.46

Technical Indicators

Market Signals
Indicator
GORO
NERV
Relative Strength Index (RSI) 63.35 42.41
Support Level $1.27 $5.02
Resistance Level $1.75 $6.69
Average True Range (ATR) 0.10 0.59
MACD 0.04 -0.12
Stochastic Oscillator 79.57 17.83

Price Performance

Historical Comparison
GORO
NERV

About GORO Gold Resource Corporation

Gold Resource Corp is a producer of metal concentrates that contain gold, silver, copper, lead, and zinc in Oaxaca, Mexico. . It targets low capital expenditure projects with the potential for generating high returns on capital. The company's two pipeline projects are; Don David Gold at Oaxaca, Mexico, and Back Forty at Michigan, United States of America. The Company has two reporting segments, based on geographic regions. Oaxaca, Mexico represents the Company's only operating segment with a production stage property. The Company's other reporting segment is Michigan, U.S.A., with an exploration stage property.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

Share on Social Networks: